Policy | August 01, 2022
Ayush Minister Sonowal inaugurates Ayush Building Complex in Navi Mumbai
Steps afoot to make RRIH & RRIUM as a Centres of Excellence for Allergic Disorder and for Regimental Therapy respectively
Steps afoot to make RRIH & RRIUM as a Centres of Excellence for Allergic Disorder and for Regimental Therapy respectively
The company is focused on therapies such as skinceuticals, gastroenterology, neuropsychiatry, cardiac diabetes care etc.
Pawar also unveiled the India Family Planning 2030 vision document and launched the Medical Eligibility Criteria (MEC) Wheel Application, E-Module of Family Planning Logistics Management System (FPLMIS) and Digital Archive on Family Planning under the category of Digital Intervention.
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
Better serving global partners and advancing healthcare innovation
Company raises the annual revenue guidance from mid-teens to high teens
The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product
PM congratulates citizens on crossing the 200 crore milestone of Covid vaccination drive
Subscribe To Our Newsletter & Stay Updated
